BMC presents patient positions on drug pricing

A group of BMC members met with the Pan-Canadian Generic Drug Value Price Initiative committee on November 6 in Toronto.  The BMC expressed support for government attempts to seek value for public drug programs while urging safeguards against any measures which would encourage switching because of cost or economic reasons as well as pricing contracts which could lead to drug shortages.

Read more by clicking here.